Thoracic Oncology Frontiers 2027

Platinum Sponsors


Diamond Sponsors


Gold Sponsors


Silver Sponsors


Join us at Thoracic Oncology Frontiers 2027

About Thoracic Oncology Frontiers

An international multidisciplinary event bridging translational research and clinical medicine, this meeting will convene global leaders across thoracic oncology to improve MDT decision making and accelerate translation of trial evidence into real-world practice.

This two day international conference will bring together leaders across the thoracic oncology pathway to explore advances in:

  • Multimodal treatment strategies 
  • Neoadjuvant & perioperative therapy 
  • Radiotherapy integration 
  • Surgical innovation 
  • Molecular selection 
  • Imaging & response assessment 
  • Oligometastatic disease

The meeting aims to improve MDT decision-making, explore sequencing of therapies and translate trial evidence into real-world pathways. 

Who is the Thoracic Oncology Frontiers for?

This conference is designed for professionals involved across the thoracic oncology pathway, including medical oncologists, clinical and radiation oncologists, thoracic surgeons, respiratory physicians, radiologists, pathologists, research leaders, nursing and allied health professionals, and guideline contributors.

Explore the Full Scientific Programme

Key Speakers

Dr Sean Dulloo (Chair)

Dr Sean Dulloo is a Consultant Medical Oncologist & Honorary Associate Professor at the University Hospitals of Leicester NHS Trust and University of Leicester. Dr. Dulloo is the current Head of Service for Oncology and clinical lead for thoracic oncology.  Dr Dulloo completed his Internal Medicine residency at the National University Health System, Singapore. He completed his Oncology training at Leicester and also successfully completed his higher research degree (MD) during this time focussing on Epithelial Mesenchymal Transition in mesothelioma.

Dr Dulloo serves as a Chief and Principal Investigator in various international clinical trials including early phase trials. His work focuses on innovative treatments for pleural mesothelioma and lung cancer. He has also presented his work at major conferences. He has published widely in high impact journals including Nature.

Prof. Jarushka Naidoo

Professor Jarushka Naidoo is a Full Professor of Medical Oncology and a Consultant Medical Oncologist at Beaumont RCSI Cancer Centre in Dublin, Ireland and an Adjunct Professor of Oncology at Johns Hopkins University.  

Dr. Naidoo graduated with her medical degree (MB BCh BAO) from Trinity College Dublin and completed internal medicine and a medical oncology training through the Royal College of Physicians of Ireland. She completed an awarded advanced medical oncology fellowship at Memorial Sloan Kettering Cancer Center (New York) and joined the faculty at Johns Hopkins University from 2015-2020. At Johns Hopkins, she led a portfolio of clinical trials and translational studies focused on immunotherapy for lung cancer and immune-related toxicity. Dr. Naidoo led several investigator-initiated trials for patients with lung cancer, with a focus on stage III non-small lung cancer and CNS metastases.  

She is a globally recognised leader in the field of immune-related toxicity, with >100 publications in this field, and her development of the multidisciplinary Johns Hopkins Immune-related Toxicity Team. She is the recipient of several grants and awards including a US NIH KL2 Clinical Scholar Award, Lung Cancer Foundation of America/IASLC Young Investigator Award. 

Since her return to Ireland, she serves as the Chair of the Lung Cancer Disease-specific subgroup (DSSG) of Cancer Trials Ireland, is the Founder and Chair of the Irish national lung cancer research group, the ‘Irish Lung Cancer Alliance,’ and a national immunotherapy toxicity network through the RCPI. She is currently a part of the ETOP, EORTC, ECOG-ACRIN and NRG Cooperative clinical trial groups, and the clinical trials portfolio in lung cancer has tripled since her return.  

Prof Naidoo was named the Irish Cancer Society’s Clinician Research Leader Award 2021. 

Be part of the next chapter in thoracic oncology

Event Venue

Leicester Marriott

Address: Grove Park, Smith Way, Enderby, Leicester, LE19 1SW, UK

Accommodation: Conference delegates can book their own overnight accomodation directly with the Marriott Leicester.

To book overnight accommodation: More details to follow up shortly.

Link to book accommodation

TOF 2026 Event Gallery